FDA Approves Gene Therapy for Duchenne Muscular Dystrophy: New Breakthrough Treatment for Young Patients
FDA Approves Gene Therapy for Duchenne Muscular Dystrophy, Limited to Young Patients In a groundbreaking development, the US Food and Drug Administration (FDA) has granted approval for a gene therapy to treat Duchenne Muscular Dystrophy (MD). This rare genetic disease primarily affects young boys and severely limits their life expectancy. The newly approved treatment, called … Read more